1,454
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Identification of a detection panel for post-transplant virus infection through integrated analysis of non-coding RNAs in peripheral blood

ORCID Icon, , , , , , , , & show all
Pages 691-698 | Received 28 Apr 2021, Accepted 22 Nov 2021, Published online: 09 Dec 2021

References

  • Barker CF, Markmann JF. Historical overview of transplantation. Cold Spring Harb Perspect Med. 2013;3(4):a014977.
  • Brandi G, Ricci AD, Rizzo A, et al. Is post-transplant chemotherapy feasible in liver transplantation for colorectal cancer liver metastases? Cancer Commun (Lond)). 2020;40(9):461–464.
  • Scanlon N, Saklawi Y, Rouphael N. The role of systems vaccinology in understanding the immune defects to vaccination in solid organ transplant recipients. Front Immunol. 2020; 11:582201.
  • Yu S, Su C, Luo X. Impact of infection on transplantation tolerance. Immunol Rev. 2019;292(1):243–263.
  • Haidar G, Singh N. Viral infections in solid organ transplant recipients: novel updates and a review of the classics. Curr Opin Infect Dis. 2017;30(6):579–588.
  • La Rosa C, Diamond DJ. The immune response to human CMV. Future Virol. 2012;7(3):279–293.
  • Sawinski D, Goral S. BK virus infection: an update on diagnosis and treatment. Nephrol Dial Transplant. 2015;30(2):209–217.
  • Shao EX, Wang CSW, Javorsky G. Parvovirus B19 induced red cell aplasia in a heart transplant patient diagnosed on pleural fluid. Transplantation. 2018;102(8):e367–e8.
  • Le J, Durand CM, Agha I, et al. Epstein-Barr virus and renal transplantation. Transplant Rev (Orlando). 2017;31(1):55–60.
  • Fishman JA. Infection in organ transplantation. Am J Transplant. 2017;17(4):856–879.
  • Limaye AP, Babu TM, Boeckh M. Progress and challenges in the prevention, diagnosis, and management of cytomegalovirus infection in transplantation. Clin Microbiol Rev. 2020;34(1).
  • Goodall GJ, Wickramasinghe VO. RNA in cancer. Nat Rev Cancer. 2021;21(1):22–36.
  • Slack FJ, Chinnaiyan AM. The role of non-coding RNAs in oncology. Cell. 2019;179(5):1033–1055.
  • Tan YT, Lin JF, Li T, et al. LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer. Cancer Commun (Lond)). 2021;41(2):109–120.
  • Vienberg S, Geiger J, Madsen S, et al. MicroRNAs in metabolism. Acta Physiol (Oxf)). 2017;219(2):346–361.
  • Nahand JS, Vandchali NR, Darabi H, et al. Exosomal microRNAs: novel players in cervical cancer. Epigenomics. 2020;12(18):1651–1660.
  • Hussen BM, Ahmadi G, Marzban H, et al. The role of HPV gene expression and selected cellular MiRNAs in lung cancer development. Microb Pathog. 2021; 150:104692.
  • Yousefpouran S, Mostafaei S, Manesh PV, et al. The assessment of selected MiRNAs profile in HIV, HBV, HCV, HIV/HCV, HIV/HBV co-infection and elite controllers for determination of biomarker. Microb Pathog. 2020; 147:104355.
  • Moghoofei M, Najafipour S, Mostafaei S, et al. MicroRNAs profiling in HIV, HCV, and HIV/HCV co-infected patients. Curr HIV Res. 2021;19(1):27–34.
  • Nahand JS, Jamshidi S, Hamblin MR, et al. Circular RNAs: new epigenetic signatures in viral infections. Front Microbiol. 2020; 11:1853.
  • Wang RQ, Long XR, Ge CL, et al. Identification of a 4-lncRNA signature predicting prognosis of patients with non-small cell lung cancer: a multicenter study in China. J Transl Med. 2020;18(1):320.
  • Yang G, Zhang Y, Yang J. A five-microRNA signature as prognostic biomarker in colorectal cancer by bioinformatics analysis. Front Oncol. 2019; 9:1207.
  • Theriault B, Wang Y, Chen L, et al. Long-term maintenance of sterility following skin transplantation in germ-free mice. Transplantation Direct. 2015;1(8):e28.
  • Mendell JT, Olson EN. MicroRNAs in stress signaling and human disease. Cell. 2012;148(6):1172–1187.
  • Takahashi K, Yamanaka S. A developmental framework for induced pluripotency. Development. 2015;142(19):3274–3285.
  • Filios SR, Shalev A. β-Cell MicroRNAs: small but powerful. Diabetes. 2015;64(11):3631–3644.
  • Bruni R, Marcantonio C, Pulsoni A, et al. microRNA levels in paraffin-embedded indolent B-cell non-Hodgkin lymphoma tissues from patients chronically infected with hepatitis B or C virus. BMC Infect Dis. 2014; 14 Suppl 5:S6.
  • Xia B, Lu J, Wang R, et al. miR-21-3p regulates influenza a virus replication by targeting histone deacetylase-8. Front Cell Infect Microbiol. 2018; 8:175.
  • Singaravelu R, O'Hara S, Jones DM, et al. MicroRNAs regulate the immunometabolic response to viral infection in the liver. Nat Chem Biol. 2015;11(12):988–993.
  • Yu M, Liang W, Wen S, et al. EphB2 contributes to human naive B-cell activation and is regulated by miR-185. FASEB J. 2014;28(8):3609–3617.
  • Belkaya S, Murray SE, Eitson JL, et al. Transgenic expression of microRNA-185 causes a developmental arrest of T cells by targeting multiple genes including Mzb1. J Biol Chem. 2013;288(42):30752–30762.
  • Fatica A, Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet. 2014;15(1):7–21.
  • Long Y, Wang X, Youmans DT, et al. How do lncRNAs regulate transcription? Sci Adv. 2017;3(9):eaao2110.
  • Xu Y, Li R, Li X, et al. An autophagy-related gene signature associated with clinical prognosis and immune microenvironment in gliomas. Front Oncol. 2020; 10:571189.
  • Thompson JC, Davis C, Deshpande C, et al. Gene signature of antigen processing and presentation machinery predicts response to checkpoint blockade in non-small cell lung cancer (NSCLC) and melanoma. J Immunother Cancer. 2020;8(2):e000974.
  • Xiao H, Wang B, Xiong HX, et al. A novel prognostic index of hepatocellular carcinoma based on immunogenomic landscape analysis. J Cell Physiol. 2021;236(4):2572–2591.
  • Zhou C, York SR, Chen JY, et al. Long noncoding RNAs expressed in human hepatic stellate cells form networks with extracellular matrix proteins. Genome Med. 2016;8(1):31.
  • Wang C, Shi X, Li W, et al. Oil species identification technique developed by Gabor wavelet analysis and support vector machine based on concentration-synchronous-matrix-fluorescence spectroscopy. Mar Pollut Bull. 2016;104(1-2):322–328.
  • Biswas S, Haleyurgirisetty M, Lee S, et al. Development and validation of plasma miRNA biomarker signature panel for the detection of early HIV-1 infection. EBioMedicine. 2019; 43:307–316.
  • Loureiro D, Tout I, Narguet S, et al. miRNAs as potential biomarkers for viral hepatitis B and C. Viruses. 2020;12(12):1440.